Testing a new drug (GEN1119) for solid tumors
Part of Cancer clinical trials.
This trial tests a new experimental drug called GEN1119 for people with solid tumors that have stopped responding to standard treatments. It's an early-phase study to see if the drug is safe and how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed solid tumor (not a blood cancer) that can be measured on scans.
- You have already tried the usual treatments for your cancer and they no longer work, or there is no standard treatment available.
- You must not have had certain prior treatments, including T-cell engagers or CAR T-cell therapy.
- You must wait at least 2 weeks after your last cancer treatment before starting this trial.
- You must not have an active hepatitis B or C infection.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new drug called BI 3822971 for people with advanced cancer that has not responded to standard treatments. The goal is to find the best dose that is safe and well-tolerated.
This trial tests an experimental drug, GEN1106, for people with solid tumors that have not responded to standard treatments. It aims to see if the drug can help shrink or control the cancer.
This trial tests an experimental drug called GEN1079 for people with advanced solid tumors that have spread or cannot be removed. The goal is to see if it's safe and if it helps shrink tumors.
This trial tests a new tablet called GEN-725 for people with advanced solid tumors that have stopped responding to standard treatments or cannot tolerate them. It aims to see if the drug is safe and how it affects the body, and may be an option if you've had prior treatment with PD-1/PD-L1 inhibitors that stopped working at least 6 months ago.
This Phase 1 trial tests an experimental drug called GenSci139 for people with advanced solid tumors (cancers that have spread) that have not responded to standard treatments. The goal is to see if the drug is safe and how well it works.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
Hear when a new Solid Tumours trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.